The Chemours Company (CC)

The Chemours Company Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-238	578	608	219	-52
Depreciation & Amortization	307	291	317	320	311
Share-Based Compensation	18	27	34	16	19
Other Operating Activities	469	-141	-145	252	372
Operating Cash Flow	556	755	814	807	650
Operating Cash Flow Growth	-26.36%	-7.25%	0.87%	24.15%	-42.98%
Capital Expenditures	-370	-307	-277	-267	-481
Acquisitions	143	33	508	5	-1
Change in Investments	-8	3	-12	27	-2
Other Investing Activities	6	-13	1	1	1
Investing Cash Flow	-229	-284	220	-234	-483
Dividends Paid	-149	-154	-164	-164	-164
Share Issuance / Repurchase	-50	-444	-150	16	-313
Debt Issued / Paid	389	-81	-237	-285	88
Other Financing Activities	-18	-7	-3	-16	-30
Financing Cash Flow	172	-686	-554	-449	-419
Exchange Rate Effect	4	-32	-34	38	-6
Net Cash Flow	503	-247	446	162	-258
Free Cash Flow	186	448	537	540	169
Free Cash Flow Growth	-58.48%	-16.57%	-0.56%	219.53%	-73.68%
Free Cash Flow Margin	3.09%	6.59%	8.46%	10.87%	3.06%
Free Cash Flow Per Share	1.25	2.97	3.29	3.28	1.03

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).